TABLE 3

Plasma Pharmacokinetic Parameters After Intravenous Administration of BAY 86-7548

Total radioactivityUnchanged tracer
ParameterCmax (%ID/mL)tmax* (min)AUC(0-tlast) (%ID*min/mL)Cmax (pmol/L)tmax* (min)AUC(0-tlast) (pmol*h/L)CL (L/h)t1/2 (min)
Arithmetic mean0.010610.60.011643810.615755.581.0
Arithmetic SD0.007661.880.001743801.8846.612.821.5
Coefficient of variation (%)72.611.015.086.811.029.723.126.5
  • * Median, minimum, and maximum are listed instead of arithmetic mean, SD, and coefficient of variation.

  • Values have to be regarded as estimates, because sampling time was not sufficient to describe terminal elimination phase adequately.

  • Injected dose of BAY 86-7548 was 140 MBq (total mass ≤ 28 µg) and number of experiments 5.

  • Cmax = maximum concentration; %ID = percentage injected dose; tmax = time of maximum; AUC = area under curve; CL = total clearance; t1/2 = plasma half-life